Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makishima

Showing results (691-700 of 737) with videos related to

Pageof 74
Sort By:
Oncotarget|December 30, 2016
Recurrent genetic defects on chromosome 5q in myeloid neoplasmsNaoko Hosono, Hideki Makishima, Reda Mahfouz, et al.
Blood|August 4, 2012
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
BMC Cancer|July 4, 2023
Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial)Osamu Shimomura, Masato Endo, Hirokazu Makishima, et al.
Blood Advances|February 23, 2019
Frequent germline mutations of <i>HAVCR2</i> in sporadic subcutaneous panniculitis-like T-cell lymphomaChantana Polprasert, Yasuhide Takeuchi, Nobuyuki Kakiuchi, et al.
Blood|July 25, 2012
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromesValeria Visconte, Heesun J Rogers, Jarnail Singh, et al.
International Journal of Cancer|April 29, 2022
The landscape of genetic aberrations in myxofibrosarcomaYasuhide Takeuchi, Kenichi Yoshida, Adriane Halik, et al.
Blood|May 4, 2012
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesisAndres Jerez, Yuka Sugimoto, Hideki Makishima, et al.
Haematologica|February 13, 2025
Overall cancer risk in people with deleterious germline <i>DDX41</i> variantsSophia C Korotev, Jason X Cheng, Yogameenakshi Haribabu, et al.
Cancer Cell|July 4, 2025
Distinct follicular T cell subsets regulate lymphoma progression and outcomesYoshiaki Abe, Junko Zenkoh, Akinori Kanai, et al.
Blood Advances|March 4, 2020
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient statusRaksha Shrestha, Mamiko Sakata-Yanagimoto, Koichiro Maie, et al.
Pageof 74

Showing results (691-700 of 737) with videos related to

Sort By:
Pageof 74
Oncotarget|December 30, 2016
Recurrent genetic defects on chromosome 5q in myeloid neoplasmsNaoko Hosono, Hideki Makishima, Reda Mahfouz, et al.
Blood|August 4, 2012
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
BMC Cancer|July 4, 2023
Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial)Osamu Shimomura, Masato Endo, Hirokazu Makishima, et al.
Blood Advances|February 23, 2019
Frequent germline mutations of <i>HAVCR2</i> in sporadic subcutaneous panniculitis-like T-cell lymphomaChantana Polprasert, Yasuhide Takeuchi, Nobuyuki Kakiuchi, et al.
Blood|July 25, 2012
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromesValeria Visconte, Heesun J Rogers, Jarnail Singh, et al.
International Journal of Cancer|April 29, 2022
The landscape of genetic aberrations in myxofibrosarcomaYasuhide Takeuchi, Kenichi Yoshida, Adriane Halik, et al.
Blood|May 4, 2012
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesisAndres Jerez, Yuka Sugimoto, Hideki Makishima, et al.
Haematologica|February 13, 2025
Overall cancer risk in people with deleterious germline <i>DDX41</i> variantsSophia C Korotev, Jason X Cheng, Yogameenakshi Haribabu, et al.
Cancer Cell|July 4, 2025
Distinct follicular T cell subsets regulate lymphoma progression and outcomesYoshiaki Abe, Junko Zenkoh, Akinori Kanai, et al.
Blood Advances|March 4, 2020
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient statusRaksha Shrestha, Mamiko Sakata-Yanagimoto, Koichiro Maie, et al.
Pageof 74